Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation.
about
Cytotoxic CD4 T cells in antiviral immunityThe Differentiation and Protective Function of Cytolytic CD4 T Cells in Influenza InfectionHuman CMV-specific T-cell responses in kidney transplantation; toward changing current risk-stratification paradigmImmune regulation of human herpesviruses and its implications for human transplantationRevealing the role of CD4(+) T cells in viral immunityCD4 T-cell immunotherapy for chronic viral infections and cancerCancer vaccinesCytotoxic CD4 T Cells: Differentiation, Function, and Application to Dengue Virus InfectionComparison of OX40 ligand and CD70 in the promotion of CD4+ T cell responsesPriming immunization with DNA augments immunogenicity of recombinant adenoviral vectors for both HIV-1 specific antibody and T-cell responsesAge-related changes in memory and effector T cells responding to influenza A/H3N2 and pandemic A/H1N1 strains in humans.Imaging effector functions of human cytotoxic CD4+ T cells specific for Plasmodium falciparum circumsporozoite protein.Self-protection of individual CD4+ T cells against R5 HIV-1 infection by the synthesis of anti-viral CCR5 ligands.Increased numbers of IL-7 receptor molecules on CD4+CD25-CD107a+ T-cells in patients with autoimmune diseases affecting the central nervous system.Autocrine production of beta-chemokines protects CMV-Specific CD4 T cells from HIV infectionHIV controller CD4+ T cells respond to minimal amounts of Gag antigen due to high TCR avidity.Regulatory function of cytomegalovirus-specific CD4+CD27-CD28- T cells.Human Cytomegalovirus Induces Cellular and Humoral Virus-specific Immune Responses in Humanized BLT MiceExhaustive expansion: A novel technique for analyzing complex data generated by higher-order polychromatic flow cytometry experiments.Absence of cross-presenting cells in the salivary gland and viral immune evasion confine cytomegalovirus immune control to effector CD4 T cells.Nef-specific CD45RA+ CD8+ T cells secreting MIP-1beta but not IFN-gamma are associated with nonprogressive HIV-1 infection.New flow cytometric assays for monitoring cell-mediated cytotoxicityInterleukin-7 receptor signaling is deficient in CD4+ T cells from HIV-infected persons and is inversely associated with aging.Impact of distinct poxvirus infections on the specificities and functionalities of CD4+ T cell responsesClearance of HIV type 1 envelope recombinant sendai virus depends on CD4+ T cells and interferon-gamma but not B cells, CD8+ T cells, or perforin.Vector choice determines immunogenicity and potency of genetic vaccines against Angola Marburg virus in nonhuman primatesRegulation of inflammatory chemokine receptors on blood T cells associated to the circulating versus liver chemokines in dengue fever.Mechanisms underlying γδ T-cell subset perturbations in SIV-infected Asian rhesus macaques.Eosinophilic gastrointestinal disease and peanut allergy are alternatively associated with IL-5+ and IL-5(-) T(H)2 responsesIdentification of immunogenic LY6K long peptide encompassing both CD4(+) and CD8(+) T-cell epitopes and eliciting CD4(+) T-cell immunity in patients with malignant diseaseHeterogeneous memory T cells in antiviral immunity and immunopathologyPostnatal acquisition of primary rhesus cytomegalovirus infection is associated with prolonged virus shedding and impaired CD4+ T lymphocyte function.T cell activation but not polyfunctionality after primary HIV infection predicts control of viral load and length of the time without therapy.Attrition of T-cell functions and simultaneous upregulation of inhibitory markers correspond with the waning of BCG-induced protection against tuberculosis in mice.Vaccine-induced CD107a+ CD4+ T cells are resistant to depletion following AIDS virus infection.Safety and immunogenicity of H1/IC31®, an adjuvanted TB subunit vaccine, in HIV-infected adults with CD4+ lymphocyte counts greater than 350 cells/mm3: a phase II, multi-centre, double-blind, randomized, placebo-controlled trial.T-cell immune responses to Wilms tumor 1 protein in myelodysplasia responsive to immunosuppressive therapySubtypes of type I IFN differentially enhance cytokine expression by suboptimally stimulated CD4(+) T cells.Glycoprotein B vaccine is capable of boosting both antibody and CD4 T-cell responses to cytomegalovirus in chronically infected women.Restoration of CMV-specific-CD4 T cells with ART occurs early and is greater in those with more advanced immunodeficiency.
P2860
Q21296742-5D32EF6F-3185-4D7B-8313-15F7B602E147Q26751016-92DE1E48-AB1C-41BC-890B-03A2787583FCQ26850340-DE94D302-6D2C-4846-B272-D59E787F0372Q26992146-B4FE4B1C-65F6-4EE8-92AA-D24BD4CCB1EFQ26995409-13840404-C755-450C-A899-44B1AADC57C4Q27022957-FC5E086F-E371-4E4A-958C-6558DB36A1CBQ27024438-3B64F1E2-5BA7-42A2-B302-49C502EF427FQ28079626-220BB0C4-A43A-4EB4-94D5-B07CB89E8D98Q28507643-D6E47622-B2D6-4776-B856-20E099981075Q28749120-50081BEC-1D61-4B94-9496-8383456CAD8FQ30400174-A41CBFBB-483B-4FAB-97B5-E621FF195331Q30497914-D91C8409-2536-4B6D-B356-CB0855018E22Q33378492-312F57BC-5D7B-4920-97E3-992150AFA7C3Q33490992-249ADEBA-FCFF-492C-8373-50983B5D03C1Q33513965-9AA15FF0-20F9-43C8-A15D-1AAFFE577F84Q33535905-FDDD80E0-1787-49F1-898B-F87D661B7F36Q33664082-299BC8F8-7570-4150-ADF4-324ADE16EAC8Q33681388-B316FF52-A05F-402A-A3F6-43AEEA2042CEQ33733632-3D57973C-EB26-4E35-A9E4-37FA9B1F0C05Q34013634-D71C3CC5-041B-4AF3-9138-8DAA7A20B6F6Q34016464-127A228D-A277-4D1E-9C72-6B150CF9B45EQ34027777-DE59D26B-5819-46A0-A3ED-0C198EF91E74Q34052036-AB5AADB8-E458-4281-B663-4B700C9B294CQ34059488-3C0988D3-5979-4672-84CF-15827ED59516Q34100215-DFB99F5B-8810-41AD-8FA7-73B3C3EEA55FQ34120895-FD35675E-4DB9-4DEC-AD25-97D9DEC8B13AQ34344625-CCB08C79-37B1-4E59-A038-97394AF6A943Q34360320-B31DC25F-B9CE-4A4B-B081-65B3AC89F3D4Q34363717-62109C86-BBA0-48B7-8B21-C0F991907542Q34372937-58767845-5EC6-4516-BE0C-B4F01241C44AQ34374787-6D0D491D-CD16-4935-B746-957E9ABF8E3AQ34430261-5D819A95-5FD4-4E18-8E0A-8FB9983007E4Q34510458-99E488EC-D6FC-4A05-975F-29BB02F553BBQ34566311-025D3A5C-DBC4-4211-813E-F8DFFF20E27DQ34594890-7E475569-C8A7-4FFE-B1E2-91473EF9F846Q34663035-9AB0BE96-273A-40F2-96FD-90A5F07E8EA0Q34707452-871F1F0C-CA04-4428-BA73-22E99613A53CQ34986260-D8409E22-CAEC-484C-AA91-6037E15F0EAEQ34988279-57FD2358-E693-4932-91D3-B8E9EA0B8431Q35018886-BC8F8002-3C07-413E-A0F5-0176CA73C4B3
P2860
Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Acquisition of direct antivira ...... ytes with cellular maturation.
@ast
Acquisition of direct antivira ...... ytes with cellular maturation.
@en
type
label
Acquisition of direct antivira ...... ytes with cellular maturation.
@ast
Acquisition of direct antivira ...... ytes with cellular maturation.
@en
prefLabel
Acquisition of direct antivira ...... ytes with cellular maturation.
@ast
Acquisition of direct antivira ...... ytes with cellular maturation.
@en
P2093
P2860
P356
P1476
Acquisition of direct antivira ...... ytes with cellular maturation.
@en
P2093
Brenna J Hill
Daniel C Douek
Jason M Brenchley
Joseph P Casazza
Laura E Ruff
Mario Roederer
Melissa L Precopio
Michael R Betts
Richard A Koup
P2860
P304
P356
10.1084/JEM.20052246
P407
P577
2006-12-11T00:00:00Z